Nabi-Hb (Hepatitis B Immune Globulin (Human))
Brand Names: Nabi-Hb
Methodology & AI Transparency ⓘ
Nabi-Hb (Hepatitis B Immune Globulin (Human)) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Marketed under the trade name Nabi-Hb (registered by ADMA Biologics, Inc., RxNorm 1658127), this prescription brand-name formulation contains Hepatitis B Immune Globulin (Human) within the Human Immunoglobulin therapeutic class.
- 2 Real-world patient consensus: Branded human immunoglobulin presentation of Hepatitis B Immune Globulin (Human) (ADMA Biologics, Inc.); generic reference: /meds/hepatitis-b-immune-globulin-human.
- 3 Typical cash cost range: 30-day cash pricing ranges from $79.78 discount cash to $211.42 walk-in retail (NADAC $0.9900/unit).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Nabi-Hb (Hepatitis B Immune Globulin (Human)) include nausea (4%), headache (14%), vomiting (2%).
Ask our AI Specialists anything about Nabi-Hb (Hepatitis B Immune Globulin (Human))
Nabi-Hb (Hepatitis B Immune Globulin (Human)) Mechanism, CYP450 Pathways & DailyMed Monograph
Marketed under the trade name Nabi-Hb (registered by ADMA Biologics, Inc., RxNorm 1658127), this prescription brand-name formulation contains Hepatitis B Immune Globulin (Human) within the Human Immunoglobulin therapeutic class. Per 2025-04-10 DailyMed labeling (69800-4203), clinical use centers on 1560 [iU]/5mL Liquid; Maintenance adjustment for Nabi-Hb (Hepatitis B Immune Globulin (Human)) based on hepatic/renal clearance: Nabi-HB, Hepatitis B Immune Globulin (Human), is indicated for treatment of acute exposure to blood containing HBsAg,.
At the receptor and enzymatic level, Nabi-Hb delivers Hepatitis B Immune Globulin (Human) to execute human immunoglobulin modulation with class-characteristic hepatorenal disposition. Specific to the Nabi-Hb commercial product (NDC 69800-4203, RxCUI 1658127), tablet/vehicle compounding registered by ADMA Biologics, Inc. standardizes delivery across 1560 [iU]/5mL Liquid; Maintenance adjustment for Nabi-Hb (Hepatitis B Immune Globulin (Human)) based on hepatic/renal clearance, contrasting $79.78 discount cash access against $211.42 walk-in retail pricing.
Clinical clearance of Nabi-Hb (Hepatitis B Immune Globulin (Human)) (Human Immunoglobulin) relies on predominantly hepatic biotransformation with renal elimination of polar nabi-hb (hepatitis b immune globulin (human)) conjugates with a Steady-state plasma equilibrium reached over 9–13 hour t½ intervals for Nabi-Hb (Hepatitis B Immune Globulin (Human)) half-life; patients absorbing at Approximately 61% to 73% enteral uptake across labeled Nabi-Hb (Hepatitis B Immune Globulin (Human)) strengths bioavailability typically observe target onset around maximum serum exposure occurs 2–4 hours after nabi-hb (hepatitis b immune globulin (human)) dosing.
FDA clinical labeling for Nabi-Hb (Hepatitis B Immune Globulin (Human)) restricts administration in confirmed ige-mediated allergy or cutaneous reaction to nabi-hb (hepatitis b immune globulin (human)) (hepatitis b immune globulin (human)) components; uncompensated hepatic or renal insufficiency incompatible with nabi-hb (hepatitis b immune globulin (human)) (1560 [iu]/5ml liquid) clearance across 1560 [iU]/5mL Liquid, Maintenance adjustment for Nabi-Hb (Hepatitis B Immune Globulin (Human)) based on hepatic/renal clearance, with self-reported patient tracking dominated by headache (14% of reports), application-site irritation (7% of reports), dizziness (6.6% of reports).
Reconcile eGFR-adjusted medications before escalating Nabi-Hb (Hepatitis B Immune Globulin (Human)) in polypharmacy regimens.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Nabi-Hb (Hepatitis B Immune Globulin (Human)) dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Confirmed IgE-mediated allergy or cutaneous reaction to Nabi-Hb (Hepatitis B Immune Globulin (Human)) (Hepatitis B Immune Globulin (Human)) components
- Uncompensated hepatic or renal insufficiency incompatible with Nabi-Hb (Hepatitis B Immune Globulin (Human)) (1560 [iU]/5mL Liquid) clearance
Logged Side-Effect Incidence (20 Reports)
Nabi-Hb (Hepatitis B Immune Globulin (Human)) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Nabi-Hb (Hepatitis B Immune Globulin (Human)))
Human clinical trial evidence for Nabi-Hb (Hepatitis B Immune Globulin (Human)) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Nabi-Hb (Hepatitis B Immune Globulin (Human)) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.9900/unit (~$29.70/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $211.42 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 20 Anonymous DotMD Community Micro-Logs | $79.78 / mo | View logs ↓ |
Nabi-Hb (Hepatitis B Immune Globulin (Human)) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Nabi-Hb (Hepatitis B Immune Globulin (Human)) RxNorm Concept ID | 1658127 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.9900 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $211.42 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $79.78 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 83.00% Worth It (20 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Nabi-Hb (Hepatitis B Immune Globulin (Human)) Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Nabi-Hb (Hepatitis B Immune Globulin (Human)): FDA labeling (2025-04-10, NDC 69800-4203), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Nabi-Hb (Hepatitis B Immune Globulin (Human)) community threads and patient logs by age, biological sex, dosage, and treatment duration.